{
  "introduction": {
    "purpose": "This document provides a detailed summary and guidance for describing drug disintegration images across eight key dimensions. The goal is to enhance accuracy, clarity, and context when describing drug disintegration processes.",
    "dimensions": [
      {
        "name": "Color Change",
        "description": "Captures the variations in color intensity, transparency, and spatial distribution during drug disintegration."
      },
      {
        "name": "Shape Change",
        "description": "Tracks the overall transformation of the drug's shape from intact to fragmented."
      },
      {
        "name": "Surface Texture Change",
        "description": "Describes changes in surface texture, including roughness, cracking, and pore formation."
      },
      {
        "name": "Volume Change",
        "description": "Monitors the reduction in tablet size, correlating with its disintegration rate."
      },
      {
        "name": "Dissolution Speed and Time",
        "description": "Captures dynamic changes in dissolution rate and particle formation over time."
      },
      {
        "name": "Physical State Change",
        "description": "Documents the internal and external structure changes, including cracking, swelling, and collapse."
      },
      {
        "name": "Dissolution Medium",
        "description": "Explores the influence of medium characteristics such as pH, surfactants, and viscosity on disintegration."
      },
      {
        "name": "Fragment Distribution with Density",
        "description": "Tracks fragment distribution and density in the dissolution medium, including movement and sedimentation."
      }
    ],
    "objective": "Each dimension includes specific criteria, examples, and detailed suggestions to ensure consistent, vivid, and thorough descriptions, supporting both qualitative and quantitative analysis."
  }
}
